Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient agrees to apply sunscreen and limit sunlight-exposure to 1 hour per day during the study~* Patient has been diagnosed with osteoporosis~* Patient has been postmenopausal for more than 6 months~* Patient has no contraindication to taking oral bisphosphonates~* Patient is eligible for dual energy x-ray absorptiometry in spine or hip~Exclusion Criteria:~* Patients with esophageal dysfunction~* Patients who can not sit or stand at least 30 minutes~* Patients who had a malignant disease or active systemic disease 5 years prior to participating in this trial~* Patients with diseases of bone or mineral metabolism besides osteoporosis or receiving therapies which affect bone metabolism or calcium metabolism~* Patients with history of major gastrointestinal disease (peptic ulcer, malabsorption, esophageal disease, gastritis, gastroduodenitis, etc.) within the last 6 months

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Alendronate sodium/Cholecalciferol
- 2 (Type: ACTIVE_COMPARATOR): Alendronate sodium

Based on this trial design, predict the completion outcome and termination type (if applicable).